Page last updated: 2024-10-26

enoxacin and Carcinoma, Squamous Cell

enoxacin has been researched along with Carcinoma, Squamous Cell in 1 studies

Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koide, N1
Kasamatsu, A1
Endo-Sakamoto, Y1
Ishida, S1
Shimizu, T1
Kimura, Y1
Miyamoto, I1
Yoshimura, S1
Shiiba, M1
Tanzawa, H1
Uzawa, K1

Other Studies

1 other study available for enoxacin and Carcinoma, Squamous Cell

ArticleYear
Evidence for Critical Role of Lymphocyte Cytosolic Protein 1 in Oral Cancer.
    Scientific reports, 2017, 02-23, Volume: 7

    Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Prolife

2017